MLL4 Peptide - N-terminal region

Aviva Systems Biology

MLL4 Peptide - N-terminal region

23

Western Blot

Research Use Only

Lyophilized powder

KMT2B

lysine methyltransferase 2B

CXXC10, DYT28, HRX2, MLL1B, MLL2, MLL4, MRD68, TRX2, WBP-7, WBP7, histone-lysine N-methyltransferase 2B, WW domain binding protein 7, histone-lysine N-methyltransferase MLL4, lysine (K)-specific methyltransferase 2B, mixed lineage leukemia gene homolog 2, myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) 4, myeloid/lymphoid or mixed-lineage leukemia protein 4, trithorax homologue 2

This is a synthetic peptide designed for use in combination with anti-MLL4 antibody (Catalog #: ARP33704_T100) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

-20°C

41116100

Human